Purple Biotech Ratios (2014-2026) | PPBT

Ratios Sep2014 Dec2014 Sep2015 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
EBIT Margin (Quarter)
EBITDA Margin (Quarter)
Operating Margin (Quarter)
Net Margin (Quarter)
FCF Margin (Quarter)
Efficiency
Assets Average (Quarter)
79.22M75.06M71.91M68.25M64.02M60.14M56.58M53.85M50.54M46.64M44.79M42.08M37.96M35.59M36.07M36.32M34.99M36.72M28.32M15.99M
Invested Capital (Quarter)
Leverage & Solvency
Interest Coverage Ratio (Quarter)
35.51144.8686.46178.8070.39317.56-366.7286.8134.70359.193.00262.71144.084.17-14.7240.17-21.31273.40109.5672.61
Debt Ratio (Quarter)
Times Interest Earned (Quarter)
35.51144.8686.46178.8070.39317.56-366.7286.8134.70359.193.00262.71144.084.17-14.7240.17-21.31273.40109.5672.61
Valuation
Enterprise Value (Quarter)
-48.06M-45.25M-46.92M-39.29M-35.77M-32.87M-15.27M-22.57M-17.91M-15.82M-15.25M-10.76M-7.31M-6.23M-1.07M-6.57M-5.55M-10.41M-9.63M-6.48M
Return Ratios
Return on Sales (Quarter)
Return on Capital Employed (Quarter)
29.08%29.97%31.00%35.66%37.09%43.87%45.64%42.28%48.04%55.93%63.48%64.38%63.30%54.19%34.51%23.88%17.66%16.39%133.51%248.21%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.02%